Watch CBS News
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Your go-to source for reliable and up-to-date news. Our mission is to deliver accurate, unbiased reporting that informs and engages our community.
© All Rights Reserved. 2024
